Immune therapies for malignant mesothelioma. - sprookjes - yvandenbroek - TriplyDB

Immune therapies for malignant mesothelioma.

Immune therapies for malignant mesothelioma.

http://www.wikidata.org/entity/Q38212149

about

Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.

P2860

Q35768107-478EECB5-57A6-4A25-9FD6-3946315F7991

P2860

Immune therapies for malignant mesothelioma.

http://www.wikidata.org/entity/Q38212149

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Immune therapies for malignant mesothelioma.

@en

type

label

Immune therapies for malignant mesothelioma.

@en

prefLabel

Immune therapies for malignant mesothelioma.

@en

P1433

Q38212149-FA20DD9B-4638-4FD9-8289-87ABFE18ECA2

P1476

Q38212149-7B603073-2FD2-4FF6-8547-A88F1E4852D4

P2093

Q38212149-1E6810EA-3427-4876-861C-2DA642702FE9

Q38212149-AB4529FB-BA96-4BAA-A108-7D5BF7937662

P2860

Q38212149-03CF424F-89CD-4321-9AE1-4961F666433A

Q38212149-0D84A5A5-24B1-4D7E-99D8-9FD24C472011

Q38212149-12585EA5-E624-4782-9921-FC63908AECA6

Q38212149-18491642-E4F4-4074-A289-D0B8067AE7CC

Q38212149-18867C47-9ECF-4992-A7E4-C6C772221563

Q38212149-1A646B92-281E-4AAB-B1B3-64CCA2D43B4E

Q38212149-1AD61C16-82B7-43F2-A9F5-34CF9B6D7EF1

Q38212149-2001AE45-EE15-467F-9468-80153CB2967F

Q38212149-22D3B644-9BF5-4F1D-8409-050997C2B33D

Q38212149-26A2CBB3-7A61-4165-885A-41A399860FD1

P304

Q38212149-71D2C7B6-E6A7-4C58-ABF2-FFAF085764EB

P31

Q38212149-C5BE1D1A-FEE7-402F-92FA-94D48568D155

P356

Q38212149-2CD6FA25-A9A2-4CDC-A24A-CDA702A7203B

P433

Q38212149-047024EB-A958-4AC1-BF3E-DAA1AA376521

P478

Q38212149-89B5ACCC-D315-4351-A2BE-6FA0AD8B6DCC

P50

Q38212149-C5D150FF-1809-4942-930C-0B1BB8B54B29

P577

Q38212149-5A6C12C0-3AD6-4A10-BDBD-61A675F38C39

P698

Q38212149-973C239A-D9B1-45A0-92AD-F80A88C40277

P356

14737140.2014.919859

P1433

Expert Review of Anticancer Therapy

P1476

Immune therapies for malignant mesothelioma.

@en

P2093

Didona Ungureanu

http://www.w3.org/2001/XMLSchema#string

Gabriel Dimofte

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma

Mesothelin: a new target for immunotherapy

Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients

Malignant mesothelioma: facts, myths, and hypotheses

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity.

Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity.

A novel high-affinity human monoclonal antibody to mesothelin.

A flow cytometry method to quantitate internalized immunotoxins shows that taxol synergistically increases cellular immunotoxins uptake

P304

965-973

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2014.919859

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Sabina Antonela Antoniu

P577

2014-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24833011

http://www.w3.org/2001/XMLSchema#string